Behavioral program for pregnant individuals with ADHD
Supporting Expectant Mothers With ADHD Through the Transition to Parenthood
This study is testing a new program to help pregnant people with ADHD manage their symptoms better during and after pregnancy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 10 (estimated) |
| Ages | 18 Years to 55 Years |
| Sex | Female |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Trial ID | NCT06540547 on ClinicalTrials.gov |
What this trial studies
This study aims to develop and test a behavioral program called MomMA (Moms Managing ADHD) for pregnant individuals diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). The program will provide skills for managing ADHD symptoms during pregnancy and after delivery, facilitated by behavioral therapists in OB care settings. The study will involve an open clinical trial with 10 participants, focusing on treatment acceptability, feasibility, and implementation factors, while also collecting qualitative and quantitative data on parent and child outcomes. The goal is to enhance family resilience and reduce the prevalence of mental health disorders in children.
Who should consider this trial
Good fit: Ideal candidates are pregnant individuals between 20- and 32-weeks of gestation who meet DSM-5 criteria for ADHD and speak English.
Not a fit: Patients with active substance use disorders, severe mental illnesses, or high-risk pregnancies may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could improve the wellbeing of both parents and children, enhancing parent-child interactions and reducing child mental health issues.
How similar studies have performed: While this approach is novel, similar interventions targeting parenting and ADHD have shown promise in other contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * (1) meet full DSM-5 criteria for ADHD * (2) are between 20- and 32-weeks of gestation * (3) speak English * (4) will deliver at the University of Pittsburgh Medical Center (UPMC) Magee Women's Hospital (MWH) Exclusion Criteria: * (1) active substance use disorder * (2) intellectual disability * (3) other severe mental illness, including bipolar disorder, psychosis, and major depressive disorder with suicidal ideation or requiring higher level of care (inpatient or partial/intensive outpatient) * (4) high risk pregnancies requiring transfer of care to Maternal-Fetal Medicine (e.g., maternal cancer, multiples, placenta accreta) and/or fetus known to have a severe congenital condition.
Where this trial is running
Pittsburgh, Pennsylvania
- UPMC Magee Women's Hospital — Pittsburgh, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Heather M Joseph, DO — University of Pittsburgh
- Study coordinator: Heather M Joseph, DO
- Email: liebherrh@upmc.edu
- Phone: 4122465339
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.